Verde Science Inc VRCI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- — / —
- Market Cap
- $23.87
- Volume/Avg
- 564,634 / 208,461
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Verde Science Inc operates as a pharmaceutical research and development company, engages in the development of pharmaceutical drugs utilizing cannabis resin. The company is focused on the discovery of drugs and treatment modalities, as well as diagnostic devices and pharmaceutical delivery systems for the treatment of diseases and medical issues. It is focused on developing medicinal formulations from cannabinoids and tetrahydrocannabinol (THC) compounds for the treatment of various issues, such as migraines, glaucoma, loss of appetite from cancer therapies, and other medical issues.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 2
- Website
- http://www.verdescienceinc.com
Valuation
|
Metric
|
VRCI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
VRCI
Financial Strength
|
Metric
|
VRCI
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.01 |
Interest Coverage | −2.42 |
Quick Ratio
VRCI
Profitability
|
Metric
|
VRCI
|
|---|---|
Return on Assets (Normalized) | −11,468.11% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
VRCI
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Gcrykrqhk | Dwy | $550.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Pvvylpyr | Ynrtyw | $101.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Mvdnkwx | Xysrqc | $98.1 Bil | |
MRNA
| Moderna Inc | Kwpbxtffk | Flxr | $39.1 Bil | |
ARGX
| argenx SE ADR | Scjnldxz | Scdqd | $21.7 Bil | |
BNTX
| BioNTech SE ADR | Fpdfkpr | Hhfr | $20.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Nzsmgkv | Rcdwmvr | $18.4 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Zwdwjvzbr | Fcclf | $17.1 Bil | |
RPRX
| Royalty Pharma PLC Class A | Lzrnpsmf | Tcprkhk | $12.5 Bil | |
INCY
| Incyte Corp | Hlhtngw | Dsghvn | $11.9 Bil |